FoundationOne Companion Diagnostic (F1CDx)

FDA Device Recall #Z-1891-2025 — Class II — February 15, 2023

Recall Summary

Recall Number Z-1891-2025
Classification Class II — Moderate risk
Date Initiated February 15, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Foundation Medicine, Inc.
Location Cambridge, MA
Product Type Devices
Quantity 1 unit

Product Description

FoundationOne Companion Diagnostic (F1CDx)

Reason for Recall

An incorrect negative claim was identified on the claims page; the device variant information was displayed correctly in the tumor profiling section of the FDA-approved test report.

Distribution Pattern

US Nationwide distribution in the state of WI.

Lot / Code Information

Report Number: ORD-XXXXX04-01; Note: The above characters have been redacted to minimize patient information disclosure.

Other Recalls from Foundation Medicine, Inc.

Recall # Classification Product Date
Z-1747-2025 Class II FoundationOne Companion Diagnostic (F1CDx) Apr 9, 2025
Z-1890-2025 Class II FoundationOne Companion Diagnostic (F1CDx) Jun 18, 2024
Z-0577-2026 Class II FoundationOne CDx (F1CDx), RAL-0003 version 31.0 Nov 8, 2022
Z-0578-2026 Class II FoundationOne Liquid CDx (F1LCDx), TECH-0009 ve... Nov 8, 2022
Z-0535-2020 Class II FoundationOne CDx test report Aug 8, 2019

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.